Panos G. Kanavos

Houghton Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 131 publications

Mapping the landscape of managed entry agreements: a systematic review of global frameworks, system-level components, and implementation challenges.

Mapping the landscape of managed entry agreements: a systematic review of global frameworks, system-level components, and implementation challenges.

Journal: Frontiers in pharmacology

Published: February 04, 2026

Reply to "On Selection and Analytical Transparency in the FRAME Framework for RWE Evaluation".

Reply to "On Selection and Analytical Transparency in the FRAME Framework for RWE Evaluation".

Journal: Clinical pharmacology and therapeutics

Published: December 09, 2025

Estimation of Future Patient Populations Eligible for Radioligand Therapies in the EU and the UK: A Modelling Study.

Estimation of Future Patient Populations Eligible for Radioligand Therapies in the EU and the UK: A Modelling Study.

Journal: The Lancet regional health. Europe

Published: November 13, 2025

Implementing sustainable liver health in Europe: a second EASL-Lancet Commission.

Implementing sustainable liver health in Europe: a second EASL-Lancet Commission.

Journal: Lancet (London, England)

Published: September 15, 2025

Why drugs fail health technology assessment: a comparative analysis of health technology assessment rejections across seven OECD countries.

Why drugs fail health technology assessment: a comparative analysis of health technology assessment rejections across seven OECD countries.

Journal: Health economics, policy, and law

Published: September 09, 2025

A strategic framework for synergizing managed entry agreement efforts to access pharmaceutical products in Saudi Arabia-results from a multi-stakeholder workshop.

A strategic framework for synergizing managed entry agreement efforts to access pharmaceutical products in Saudi Arabia-results from a multi-stakeholder workshop.

Journal: Journal of medical economics

Published: May 15, 2025

Estimation of lifetime benefits from the optimization of secondary prevention in patients with established atherosclerotic cardiovascular disease.

Estimation of lifetime benefits from the optimization of secondary prevention in patients with established atherosclerotic cardiovascular disease.

Journal: European journal of preventive cardiology

Published: January 22, 2025

Estimation of lifetime benefits from the optimisation of secondary prevention in patients with established atherosclerotic cardiovascular disease.

Estimation of lifetime benefits from the optimisation of secondary prevention in patients with established atherosclerotic cardiovascular disease.

Journal: European journal of preventive cardiology

Published: January 22, 2025

From Vision to Reality: The EU's Pharmaceutical Reforms and the Path to Improved Access.

From Vision to Reality: The EU's Pharmaceutical Reforms and the Path to Improved Access.

Journal: PharmacoEconomics - open

Published: December 30, 2024

FRAME: Framework for Real-World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness - An Evaluation of Regulatory and Health Technology Assessment Decision Making.

FRAME: Framework for Real-World Evidence Assessment to Mitigate Evidence Uncertainties for Efficacy/Effectiveness - An Evaluation of Regulatory and Health Technology Assessment Decision Making.

Journal: Clinical pharmacology and therapeutics

Published: December 03, 2024

Use of the ESMO-Magnitude of Clinical Benefit Scale to guide HTA recommendations on coverage and reimbursement for cancer medicines: a retrospective analysis.

Use of the ESMO-Magnitude of Clinical Benefit Scale to guide HTA recommendations on coverage and reimbursement for cancer medicines: a retrospective analysis.

Journal: The Lancet. Oncology

Published: April 27, 2024

Assessing the Value of Provider-Facing Digital Health Technologies Used in Chronic Disease Management: Toward a Value Framework Based on Multistakeholder Perceptions.

Assessing the Value of Provider-Facing Digital Health Technologies Used in Chronic Disease Management: Toward a Value Framework Based on Multistakeholder Perceptions.

Journal: Medical decision making : an international journal of the Society for Medical Decision Making

Published: October 26, 2023

Showing 1-12 of 131

Last Updated: 09/26/2026